Efficacy and safety of repeated use of lusutrombopag prior to radiofrequency ablation in patients with recurrent hepatocellular carcinoma and thrombocytopenia

AIMS: Thrombocytopenia is often associated with chronic liver disease. Lusutrombopag is a small molecule thrombopoietin receptor agonist designed to temporarily increase the platelet count in patients with chronic liver disease for whom elective invasive procedures are planned. In the present study,...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Hepatol Res
Autori principali: Ishikawa, Toru, Okoshi, Marina, Tomiyoshi, Kei, Kojima, Yuichi, Horigome, Ryoko, Imai, Michitaka, Nozawa, Yujiro, Iwanaga, Akito, Sano, Tomoe, Honma, Terasu, Yoshida, Toshiaki
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2019
Soggetti:
Short Communication
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6849762/
https://ncbi.nlm.nih.gov/pubmed/30602063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hepr.13305
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi